Risk Factors for Early Recurrent Clostridium difficile-Associated Diarrhea

Recurrence is a common sequela of Clostridium difficile-associated diarrhea (CDD) and may increase morbidity, costs, and treatment-related antimicrobial resistance. Because recurrent CDD (RCDD) frequently occurs very soon after an initial episode, our goal was to determine the risk factors for early...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 26; no. 4; pp. 954 - 959
Main Authors Do, Ann N., Fridkin, Scott K., Yechouron, Ariane, Banerjee, Shailen N., Killgore, George E., Bourgault, Anne Marie, Jolivet, Marie, Jarvis, William R.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.04.1998
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recurrence is a common sequela of Clostridium difficile-associated diarrhea (CDD) and may increase morbidity, costs, and treatment-related antimicrobial resistance. Because recurrent CDD (RCDD) frequently occurs very soon after an initial episode, our goal was to determine the risk factors for early RCDD (occurring ⩽45 days after the initial episode). We conducted a case-control study, comparing 13 patients with early RCDD (case patients) with 46 patients who had only one CDD episode (control patients) at Centre Hospitalier Angrignon (Québec) during January 1993 through November 1994. Risk factors for early RCDD included a history of chronic renal insufficiency, a white blood cell count of ⩾15 1 103/mm3, and community-acquired diarrhea with the first CDD episode. For seven of eight case patients, C. difficile strains from the first and second CDD episodes were identical, suggesting that relapse is more common than reinfection. These results suggest that treatments should be directed at preventing relapses in patients at high risk for early RCDD.
Bibliography:ark:/67375/HXZ-LZW46P2J-H
Reprints or correspondence: Dr. William R. Jarvis, Hospital Infections Program, Centers for Disease Control and Prevention, Mail Stop E-69, Atlanta, Georgia 30333.
istex:FC08531DD7E3A047F66B9225441B79E1E4DC521C
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1058-4838
1537-6591
DOI:10.1086/513952